|
楼主 |
发表于 2008-12-16 14:37:43
|
显示全部楼层
参考文献:7 g# E# p5 j2 u, |
E C Keystone. Advances in targeted therapy: safety of biological agents. Ann Rheum Dis.,2003.(Supplfl):ii34一ii36 " z! r& P" u5 T/ A
Peter K. Gregersen, Richard Bucala. Macrophage Migretion Inhibitory Factor, MIF Allels, and the Genetics of Inflammatory Disorders: Incorporating Disease Outcome Into the Definition of Phenotype. Arthritis&Rheumatism, 2003.48(5):1171一1176 8 H/ Q' _. k# X7 E7 l5 a" ~, ?( d
Cora Vizcarra. New Perspectives and Emerging Therpies for Immune-mediated inflammatory Disorders. Journal of InfusionNursing, 2003.26(5):319一325
. v' k3 i2 `3 P: Z9 F8 G7 o Hiroaki Ito. IL-6 and Corhn' s disease. Current Drug Targets-inflammation&Allergy, 2003.2:125一130
6 X6 T9 a. k+ r* g. K ^. L Carol Dukes Hamilton. Tuberculosis in the Cytokine Era: Whgt Rheumatologists Need to Know. Arthritis&Rheumatism,2003.48(8):2085一2091 / e8 }6 t, J8 u% V0 N* f$ c
Gary S. Firestein. Evolving concepts of rheumatoid arthritis. Nature, 2003.423(15):356一361 & W* [! a: Z: D2 v" N! J
Peter K. K. Wong, Ian K. Campbell, Paul Jean et al. The Role of the Interleukin-6 Family of Cytokines in Inflammatory Arthritis and Bone Turnover. Arthritis& Rheumatism, 2003.48(5):1177一1189
4 d! Q9 r8 i5 W* X& \ F Y Liew, X-Q Wei, I B Mclnnes. Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis.,2003.62(SupplIj):ii48一550 # S, R, Z- D. z1 F
I B Mclnnes, J A Gracie, M Harnett, F Y Liew. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis.,2003.62(Supp1II):ii51一ii54 & ?; e1 L* W( W. ~
Krishna M. sundar, Marc V. Gosselin, et al. Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of disease. Pulmonary Langerhans Cell Histiocytosis. Chest, 2003.123:1673一1683 7 m4 b3 b7 B& x8 @! h# c! |
PD Robbins, CH Evans, Y Chernajovsky. Gene therapy for arthristis. Gene Therapy, 2003.10:902一911 9 i3 e2 p/ s* p6 N. @# x& w1 \/ v
Tohru Abe, Tsutomu Takeuchi. Rheumatoid Arthritis and Tumor Necrosis Factor a. Autommunity, 2001.34:291一303 + J+ w' t. [. y7 ~. G
Ernest H. S. Choy, Grbriel S. Panayi: Cytokine pathways and joint inflammatory in rheumatoid arthritis. Mechanisms of Disease. N Engl J Med, 2001.344(12):22
+ O9 y$ t! q, U: ? Leonardo Punzi, Lorenzo Calo, Mario Plebani. Clinical Significance of Cytokine Determination in Synovial Fluid. Critical Reviews in Clinical Laboratory Sciences, 2002. 39(1) :63一88 3 P( T! C6 k4 |! @( K R
Joseph C. Shanahan, E. William St. Clair. Tumor Necrosis Factor-a Blockade: A Novel Therapy for Rheumatic Disease. Clinical Immunology, 2002 ,103 (3) :231一242, Part 1 of 2 parts
5 n6 `# f9 i" E7 H Naoyuki Tsuchiya, Jun Ohashi, Katsushi Tokunaga. Variations in immune response genes and their associations with multifactorial immune disorders. Immunological Reviews, 2002.190:169一181
[5 ?3 {. t& m 成冰燕,王占元.细胞因子与类风湿关节炎治疗的研究进展.药学实践杂志,2000.18(3):143一144
/ m; b. m+ i- v 王玉树.类风湿关节炎治疗靶点研究进展.国外医学预防、诊断、治疗用生物制品分册,2002.25(5):222一226 $ c, f$ O' w' E! ]- [" O6 ]. h0 k
F Y Liew, I B McInnes. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis.,2002.61 (suppl 11) : ii 100一ii102 0 h7 @9 d: I- |5 s
张信来,刘陶迪 类风湿关节炎与白细胞介素-1.生理科学进展,1999.30(3):252一254 ( N5 k; t# F6 { x' T3 g: t
费克香,雷元卫.类风湿关节炎免疫功能异常的研究进展.国外医学免疫学分册,1999.22(6):323一326
, G$ |% X7 }+ c' n' j( A8 Z Thomas Pap,Ulf Muller-Ladner. Renate Gay&Steffen Gay: Gene Therapy Promising For Rheumatoid Arthritis. Arthritis Res.,1999. 1(1):5一9 / r& r# s& }( g7 W* O. h
Jean-Michel Dayer, Barry Bresnihan. Targeting Interleukin1 in the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatism. 2002,46(3)574一578 # G3 E! y3 k a, C" R4 l& M4 q
黄启阳,于孟学,姜玉娟,董怡.应用细胞因子及其拮抗剂治疗类风湿关节炎的进展.北京医学,1996.18(2):102一105
% }# |0 Q: N2 g9 U8 O) T+ f Wim B van den Berg. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res.,2001.3:18一26 - e( _. Q X: Y5 o! U
Katsuhiko Ishihara, Toshio Hirano. IL-6 in autoimmune disease and chronic inflammatory prolixferative disease. Cytokine & Crowth Factor Reviews, 2002.13:357一368
0 K1 x0 I4 H- J9 v0 c2 k Yoichiro Iwakura. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine & Crowth Factor Reviews, 2002.13:341一355 |
|